TRPA1 and ischemia: The i.p. administration of HC-030031, a TRPA1 antagonist (10, 30 and 50 mg/kg), immediately before initiating ischemia significantly attenuated the duration of licking in a dose-dependent manner (F3,21 = 20.0, p < 0.011).